[Association of VM26, mitomycine C, methotrexate in patients with metastatic carcinoma of the breast resistant to a combination of 4 drugs including adriamycin. Results of a type II study (autohr's transl)].
作者信息
Pouillart P, Palangie T, Jouve M, Garcia-Giralt E, Magdelenat H
出版信息
Nouv Presse Med. 1979;8(33):2690.
PMID:493073
Abstract
摘要
相似文献
1
[Association of VM26, mitomycine C, methotrexate in patients with metastatic carcinoma of the breast resistant to a combination of 4 drugs including adriamycin. Results of a type II study (autohr's transl)].VM26、丝裂霉素C、甲氨蝶呤联合应用于对包括阿霉素在内的4种药物联合方案耐药的乳腺癌转移患者。一项II型研究结果（作者译）
Nouv Presse Med. 1979;8(33):2690.
2
3
Combined chemotherapy in the management of metastatic bladder cancer.联合化疗在转移性膀胱癌治疗中的应用
Br J Urol. 1981 Aug;53(4):318-9. doi: 10.1111/j.1464-410x.1981.tb03187.x.
4
[Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Gan To Kagaku Ryoho. 1983 Mar;10(3):824-8.
5
Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
Cancer Treat Rep. 1977 Jan-Feb;61(1):87-8.
6
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Cancer Chemother Pharmacol. 1982;7(2-3):231-3. doi: 10.1007/BF00254557.
7
8
[Chemotherapy of bladder tumors].
Lille Med. 1978 Aug-Sep;23(7):486-9.
9
Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
Panminerva Med. 1981 Jan-Mar;23(1):25-8.
Zotero 插件